Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
12/2000
12/05/2000US6156737 Therapy for hepatitis b
12/05/2000US6156734 Cardiovascular disorders
12/03/2000CA2281430A1 Skin care compositions and their use in healing injured skin
11/2000
11/30/2000WO2000071557A1 13-methyl-erythromycin derivatives
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071104A2 Use of bisphosphonic acids for treating angiogenesis
11/30/2000WO2000041546A3 Novel exendin agonist formulations and methods of administration thereof
11/30/2000WO2000035434A3 Compositions and methods for the treatment of anorectal disorders
11/30/2000CA2374049A1 Use of bisphosphonic acids for treating angiogenesis
11/29/2000EP1054955A2 Compositions comprising viruses and methods for concentrating virus preparations
11/29/2000CN1275123A Prostaglandin agonists and their use to treat bone disorders
11/29/2000CN1275082A Solid oral dosage form comprising combination of metformin and glibenclamide
11/29/2000CN1275078A Use of 11-(3-dimethylaminoprpylidene)-6,11-dihydrodibenz [b,e] oxepin-2-acetic acid for manufacture of medicament for treating non-allergic ophthalmic inflammatory disorders
11/29/2000CN1275074A Dyeing composition for keratinous fibres with cationic direct colouring agent and silicone
11/29/2000CN1275073A Dyeing composition for keratinuous fibres with direct cationic colouring agent and non-ionic surfactant
11/29/2000CN1274711A New intermediate for preparation of anti-histamine piperidine derivatives
11/29/2000CN1274602A Externally applied medicated wine for treating traumatic injury and rheumatism
11/28/2000US6153751 Preparing the antiviral b-isomer of a 1,3-oxathiolane nucleoside by reacting in presence of stannic chloride
11/28/2000US6153622 Estrogen agonists/antagonists
11/28/2000US6153224 Carrier particles for use in dry powder inhalers
11/28/2000CA2267136C Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/23/2000WO2000016746A3 Immunogenic liposome compositions
11/23/2000WO1999048482A3 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
11/22/2000EP1052997A1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation
11/22/2000EP1052974A2 Compositions containing organic compounds
11/22/2000EP1052973A1 Transmucosal formulations of levosimendan
11/22/2000CN1274287A Compsn. and method of treating cancer with tannic acid and tannin complexes
11/21/2000US6150418 Propellant-free concentrate suitable for storage containing given concentration of formoterol, or salt or addition products thereof as active substance in a solvent or suspension agent; use in inhalation therapy
11/21/2000US6150380 Crystalline form of omeprazole
11/21/2000CA2010085C Pentamidine solutions
11/16/2000WO2000067759A1 Novel, specific inhibitors of acute and chronic inflammation
11/16/2000WO2000067722A1 Methods of exfoliation using n-acetyl glucosamine
11/16/2000WO2000067713A1 Antiperspirant stick
11/16/2000WO2000034331A3 Analogues of glp-1
11/16/2000CA2373504A1 Antiperspirant stick composition
11/16/2000CA2373052A1 Novel, specific inhibitors of acute and chronic inflammation
11/16/2000CA2369605A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/15/2000EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
11/15/2000EP1051425A2 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
11/15/2000EP1051186A2 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
11/15/2000CN1058394C Method for pharmaceutical based on plants for raising and adjusting tension of smooth muscle organ
11/14/2000US6146632 Vaccines
11/14/2000CA2105912C Nadh and nadph as drugs for treating alzheimer's disease
11/09/2000WO2000066603A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
11/09/2000WO2000066602A1 3-deoxy-desmycosin derivatives and process for their preparation
11/09/2000WO2000066584A1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
11/09/2000WO2000066556A1 Indoline derivatives as progesterone antagonists
11/09/2000WO2000066179A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000WO2000066164A1 Contraceptive compositions containing antiprogestinic and progestinic
11/09/2000WO2000066115A1 Device and method for prophylaxis of migraine
11/09/2000WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
11/09/2000WO2000030671A3 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
11/09/2000WO2000030668A3 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
11/09/2000DE19921192A1 Antitranspirant-Stift Antiperspirant stick
11/09/2000CA2388658A1 1-amino triazolo[4,3-a]quinazolin-5-ones and or -5-thiones inhibiting phosphodiesterase iv
11/09/2000CA2372977A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
11/09/2000CA2372773A1 Contraceptive compositions containing antiprogestinic and progestinic
11/09/2000CA2371766A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000CA2371638A1 Indoline derivatives as progesterone antagonists
11/09/2000CA2368249A1 3-deoxy-desmycosin derivatives and process for their preparation
11/08/2000EP1050294A1 Tooth pastes
11/08/2000EP1049447A1 Dyeing composition for keratinous fibres with a cationic direct colouring agent and a silicone
11/08/2000EP0652872B1 Optically pure magnesium -salt of pyridinylmethyl sulfinyl-1h-benzimidazole compound
11/08/2000CN1272845A Process for preparation of oxymorphone, oxycodone and derivatives
11/08/2000CN1272792A Herbal extract composition and method with immune-boosting capability
11/07/2000US6143771 Benzimidazole derivative drugs
11/07/2000US6143744 Sulfamide-metalloprotease inhibitors
11/07/2000US6143326 Therapy for osteoporosis
11/07/2000CA2080223C Thiophene sulfonamides useful as carbonic anhydrase inhibitors
11/07/2000CA2075711C Vaccine and method therefor
11/07/2000CA1341136C Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
11/02/2000WO2000064450A1 Pharmaceutical composition
11/02/2000WO2000033878A3 Stabilization of macrolides
11/02/2000EP1047668A1 Triazepinones, process for their preparation and their therapeutic application
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
11/02/2000EP1047455A1 Para-hydrogen labelled agents and their use in magnetic resonance imaging
11/02/2000EP1047415A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
11/02/2000EP1047390A2 Dual component antiplaque dentifrice composition
11/02/2000EP1047389A1 Dyeing composition for keratinous fibres with direct cationic colouring agent and a non-ionic surfactant
11/02/2000EP1047388A1 Dyeing composition for keratinous fibres with a direct cationic colouring agent and a surfactant
11/02/2000EP1047387A1 Dyeing composition for keratinous fibres with direct cationic colouring agent and a quaternary ammonium salt
11/01/2000CN1272105A Compound containing six-membered rings, processes for their preparation, and their use as medicaments
11/01/2000CN1057908C Use of hyaluronic acid and forms to prevent arterial restenosis
10/2000
10/31/2000US6140343 Cholesteryl ester transfer protein inhibitors which are used to elevate highdensity lipoprotein-cholesterol and to lower low density lipoprotein-cholesterol and triglycerides; for treating atherosclerosis, peripheral vascular disease, obesity
10/31/2000US6139818 Method of making ultrasonic contrast agent
10/31/2000CA2204180C Melt-extruded orally administrable therapeutically active formulations
10/31/2000CA2189658C Controlled-release dosage forms of azithromycin
10/31/2000CA2020955C Oral osmotic device with hydrogel driving member
10/26/2000WO2000063223A1 Novel 8a- and 9a-15-membered lactams
10/26/2000WO2000062800A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/26/2000WO2000062784A1 Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases
10/26/2000WO2000062756A1 SKIN CLEANING METHOD FOR ELIMINATING COMEDONES AND SCALES FROM PARTS OF THE SKIN SUBJECTED TO THE PROLIFERATION OF $i(CANDIDA ALBICANS)
10/26/2000WO2000062750A1 Oral care composition
10/26/2000WO2000037646A3 Group b streptococcus proteins, and their use
10/26/2000WO2000037064A3 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
10/26/2000WO2000025746A3 A process for the preparation of suspensions of drug particles for inhalation delivery
10/26/2000DE19917548A1 Stable topical pharmaceutical composition for treating skin diseases, especially acne, contains erythromycin higher fatty acid salt in liquid or viscous carrier
10/26/2000CA2370273A1 Novel 8a- and 9a-15-membered lactams
10/26/2000CA2365371A1 Skin cleaning method for eliminating comedones and scales from parts of the skin subjected to the proliferation of candida albicans
10/25/2000WO2000057848A1 Oxidation dyeing method using n-acetylcysteine as a reducing agent and laccase as an oxidating agent
1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 295